OnQ Blog

Spurious tales unfairly sway the patent debate

Dec 18, 2015

Qualcomm products mentioned within this post are offered by Qualcomm Technologies, Inc. and/or its subsidiaries.

Laurie Self is Vice President and Counsel of Government Affairs at Qualcomm Incorporated. Based in Washington, D.C., Laurie supports initiatives to promote strong intellectual property rights in emerging markets and ensures that laws and policies provide the necessary protections and incentives to support Qualcomm’s R&D-driven business model. The views expressed are the author’s own, and do not necessarily represent the views of Qualcomm.

There is a lesson in the latest book by “Freakonomics” authors Steven Levitt and Stephan Dubner that Washington policymakers would do well to read.

The passage from the book, “Think Like a Freak,” is about the use of anecdotes, stories, and the persuasive power of narrative.

By “story,” the authors say, what they don’t mean is “anecdote.”

“An anecdote is a snapshot, a one-dimensional shard of the big picture. It is lacking in scale, perspective, and data,” they write. “An anecdote is something that once happened to you, or to your uncle, or to your uncle’s accountant. It is too often an outlier, the memorable exception that gets trotted out in an attempt to disprove a larger truth. … Anecdotes often represent the lowest form of persuasion.”

In contrast, they say, a story “fills out the picture.”

“It uses data, statistical or otherwise, to portray a sense of magnitude; without data, we have no idea how a story fits into the larger scheme of things,” Levitt and Dubner write, adding that a good story includes a time frame that gives the audience enough reference to judge whether the phenomenon in question is noteworthy or anomalous. “A story lays out a daisy chain of events, to show the causes that lead up to a particular situation and the consequences that result from it.”

When I recently read this passage, I was struck by how well the dynamic of anecdote versus story captures the heated Washington debate over patent legislation we have witnessed in the past few years.

The “patent troll” narrative—fueled by anecdotal tales of mom-and-pop operations snared by fraudulent patent suits, and the image of ugly green trolls paraded from the House floor to the White House—became the conventional wisdom on patents almost overnight. The only “data” offered to support the narrative were compiled from surveys with unscientific methodologies, nonrandomized survey bases, and ill-defined notions of a “troll” that swept in universities, small inventors, and anyone who owned a patent but didn’t manufacture, market, and distribute the related product.

So backers of the “troll” campaign ferried to Capitol Hill a series of witnesses who spoke about the bullying and unjust demand letters they received threatening unmerited patent lawsuits. And members of Congress—forgetting another truism voiced by Levitt and Dubner, “The plural of anecdote is not data”—ate up these tales of woe.

This is not to dismiss the troubles suffered by these witnesses and others like them. We have, unfortunately, seen high-profile incidents in which patents have been abused. In one case, the Federal Trade Commission accused a company and its law firm of using deceptive sales claims and phony legal threats in letters that told thousands of small businesses around the country they were guilty of patent infringement. The agency made headlines when it barred the company and law firm from making deceptive representations when asserting patent rights. But when that case comes up in the “troll” debate, what’s forgotten is that the FTC was able to use existing consumer protection authority to deal with that kind of deception, that kind of fraud.

The House Energy and Commerce Committee has worked on a bill, the Targeting Rogue and Opaque Letters Act, or TROL Act, that specifically targets this kind of abusive use of demand letters without hurting the rights of all patent owners. But this bill has been far from the center ring of Congress’s patent legislation.

The broader, misleading “troll” narrative propelled the creation of omnibus patent legislation in the House that threatened to shake up nearly every aspect of the legal protections granted by patents—at a time when provisions of the 2011 America Invents Act overhaul of patent law were still coming into effect. The “troll” narrative had become so ingrained so quickly that the resulting “Innovation Act” passed the House by a huge majority in late 2013 before most members had any chance to read and understand it.

Well, that was nearly two years ago. The push for massive patent legislation lost momentum in the Senate by the middle of last year as universities, invention companies, and others explained to senators and their staff the dangers of so drastically weakening patents.

What helped were genuine stories.

I work for Qualcomm, and our well-documented story is one I tell often. We are a company that cares deeply about the strength and credibility of the patent system, because it’s so important to our business and our ability to keep inventing the technologies that make possible smartphones and the countless mobile capabilities everyone now takes for granted in our daily lives. We can afford the years and billions of dollars of R&D that tames the laws of physics for the sake of mobile technology, because patents allow us to license use of that technology and then plug the resulting revenue back into R&D.

University representatives told their stories of how patents allow their research and breakthroughs to become commercialized medical cures and technological wonders. The venture-capital community mapped out how patents make possible investment in risky start-ups with breakthrough ideas. Historians of the patent system and economists who study empirical data to understand innovation have filled in the stories with verifiable data and facts—and the context of two centuries of patent experience.

Still, the same patent legislation—and by "same," I mean exactly the same as in the House—was introduced at the start of the new Congress last January. But the legislation has stalled again, in what I hope is a triumph of story over anecdote. Stories are powerful, especially when the average staff person or member on Capitol Hill has five minutes to understand a complicated subject. Stories can get their attention and the chance to offer real data, real context, the complicated picture that is the patent litigation landscape. I have the impression that the Congressional leadership has become more aware of the more problematic aspects of the legislation.

I hope this opens the door to narrower, more targeted bills that have been introduced in both the House and Senate that would address the problematic and abusive use of patent demand letters without weakening patent protection for all.

That would be a just conclusion to the story of recent patent legislation.

A version of this story appeared on IPWatchdog in November 2015. 

Opinions expressed in the content posted here are the personal opinions of the original authors, and do not necessarily reflect those of Qualcomm Incorporated or its subsidiaries ("Qualcomm"). Qualcomm products mentioned within this post are offered by Qualcomm Technologies, Inc. and/or its subsidiaries. The content is provided for informational purposes only and is not meant to be an endorsement or representation by Qualcomm or any other party. This site may also provide links or references to non-Qualcomm sites and resources. Qualcomm makes no representations, warranties, or other commitments whatsoever about any non-Qualcomm sites or third-party resources that may be referenced, accessible from, or linked to this site.

Laurie Self

VP and Counsel, Govt Affairs

©2021 Qualcomm Technologies, Inc. and/or its affiliated companies.

References to "Qualcomm" may mean Qualcomm Incorporated, or subsidiaries or business units within the Qualcomm corporate structure, as applicable.

Qualcomm Incorporated includes Qualcomm's licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a wholly-owned subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm's engineering, research and development functions, and substantially all of its products and services businesses. Qualcomm products referenced on this page are products of Qualcomm Technologies, Inc. and/or its subsidiaries.

Materials that are as of a specific date, including but not limited to press releases, presentations, blog posts and webcasts, may have been superseded by subsequent events or disclosures.

Nothing in these materials is an offer to sell any of the components or devices referenced herein.